Upon tumor progression, 6 lung-residing myeloid subsets increased compared to healthy mice: MHC-IIhigh and MHC-IIlow tumor-associated macrophages (TAMs), inflammatory Ly6C+ monocytes, residential Ly6C- monocytes and angiogenic Tie2+ monocytes next to conventional type 2 dendritic cells (cDC2) (Figure 2C, upper row). This evidence concerns the gene TEK and neoplasm.